Anti-VEGF outperforms grid laser treatment for macular edema after BRVO

Intravitreal ranibizumab improved and sustained vision better than grid laser treatment in eyes with macular edema secondary to branch retinal vein occlusion, according to a study. The prospective randomized trial included 36 patients with vision loss in one eye from macular edema attributed to BRVO.

Full Story →